FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Feuerbach Mark

2. Date of Event Requiring Statement (MM/DD/YYYY)
3/15/2019 

3. Issuer Name and Ticker or Trading Symbol

Innophos Holdings, Inc. [IPHS]

(Last)        (First)        (Middle)

259 PROSPECT PLAINS RD., BUILDING A

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Interim CFO /

(Street)

CRANBURY, NJ 08512       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.001   26887   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase Common Stock     (2) 3/30/2022   Common Stock   352   $50.12   D    
Option to purchase Common Stock     (3) 3/29/2023   Common Stock   946   $54.59   D    
Option to purchase Common Stock     (4) 3/28/2024   Common Stock   2688   $55.49   D    
Option to purchase Common Stock     (5) 3/31/2025   Common Stock   3510   $49.54   D    
Option to purchase Common Stock     (6) 3/31/2026   Common Stock   8694   $31.11   D    
Option to purchase Common Stock     (7) 3/31/2027   Common Stock   4319   $52.51   D    
Option to purchase Common Stock     (8) 3/31/2028   Common Stock   6937   $39.28   D    

Explanation of Responses:
(1)  Includes 3,934 restricted shares which are subject to certain vesting and forfeiture provisions.
(2)  The reporting person was granted options on March 30, 2012. Options vested in three equal annual installments beginning on March 30, 2013.
(3)  The reporting person was granted options on March 29, 2013. One third of the options vested on March 29, 2014, one third of the options vested on March 29, 2015, and one third of the options vested on March 29, 2016.
(4)  The reporting person was granted options on March 28, 2014. One third of the options vested on March 28, 2015, one third of the options vested on March 28, 2016 and one third of the options vested on March 28, 2017.
(5)  The reporting person was granted options on May 8, 2015. Options vested in three equal annual installments beginning March 31, 2016.
(6)  The reporting person was granted options on April 1, 2016. Options vest in three equal annual installments beginning March 31, 2017.
(7)  The reporting person was granted options on April 3, 2017. Options vest in three equal annual installments beginning March 31, 2018.
(8)  The reporting person was granted options on April 2, 2018. Options will vest in three equal annual installments beginning March 31, 2019.

Remarks:
Effective March 15, 2019, the reporting person became a Section 16 officer in connection with his appointment as Interim Chief Financial Officer.


Exhibit 24 (Power of Attorney) attached

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Feuerbach Mark
259 PROSPECT PLAINS RD.
BUILDING A
CRANBURY, NJ 08512

Interim CFO

Signatures
/s/ Mark Feuerbach 3/18/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Innophos (NASDAQ:IPHS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Innophos.
Innophos (NASDAQ:IPHS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Innophos.